Simplex Trading’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,075
Closed -$5.09K 8302
2018
Q4
$3K Buy
1,075
+758
+239% +$5.27K ﹤0.01% 6507
2018
Q3
$3K Sell
317
-2,068
-87% -$16.5K ﹤0.01% 7027
2018
Q2
$17K Buy
+2,385
New +$16.6K ﹤0.01% 6014
2018
Q1
Sell
-597
Closed -$4.93K 7320
2017
Q4
$5K Buy
597
+541
+966% +$3.54K ﹤0.01% 4611
2017
Q3
$0 Sell
56
-2,177
-97% -$22.5K ﹤0.01% 7081
2017
Q2
$28K Sell
2,233
-7,787
-78% -$92.2K ﹤0.01% 2966
2017
Q1
$105K Sell
10,020
-11,625
-54% -$124K ﹤0.01% 1714
2016
Q4
$199K Buy
21,645
+20,645
+2,065% +$233K 0.01% 1058
2016
Q3
$11K Sell
1,000
-41,884
-98% -$637K ﹤0.01% 3564
2016
Q2
$554K Buy
42,884
+40,960
+2,129% +$597K 0.04% 480
2016
Q1
$30K Buy
+1,924
New +$36.5K ﹤0.01% 2443

Simplex Trading's INSY Position: Q1 2019 in Review

Simplex Trading sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 1,075 shares — an estimated $5.09K sold.

Simplex Trading first reported a position in INSY in Q1 2016 and held it in 11 quarters. The position peaked at $554K in Q2 2016. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

  • Simplex Trading reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 1,075 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $5.09K.
  • Simplex Trading first reported a position in Insys Therapeutics, Inc. in Q1 2016 and held it in 11 quarters.
  • Simplex Trading's Insys Therapeutics, Inc. position peaked at $554K in Q2 2016.
  • 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.